Imagion Biosystems Limited (IBXXF)
IBXXF Stock Price Chart
Explore Imagion Biosystems Limited interactive price chart. Choose custom timeframes to analyze IBXXF price movements and trends.
IBXXF Company Profile
Discover essential business fundamentals and corporate details for Imagion Biosystems Limited (IBXXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
21 Sept 2020
Employees
—
Website
https://imagionbiosystems.comCEO
Robert Romeo Proulx
Description
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
IBXXF Financial Timeline
Browse a chronological timeline of Imagion Biosystems Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Feb 2026
Upcoming earnings on 26 Feb 2026
Earnings released on 28 Aug 2025
Earnings released on 30 May 2025
Earnings released on 24 Mar 2025
EPS came in at -$0.01 , while revenue for the quarter reached $637.56K .
Earnings released on 28 Oct 2024
Earnings released on 30 Aug 2024
EPS came in at -$0.03 , while revenue for the quarter reached $1.09M .
Earnings released on 30 Apr 2024
Earnings released on 29 Feb 2024
EPS came in at -$0.10 , while revenue for the quarter reached $508.34K .
Earnings released on 30 Jan 2024
Stock split effective on 16 Nov 2023
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at -$0.18 , while revenue for the quarter reached $458.24K .
Earnings released on 31 Mar 2023
EPS came in at -$0.09 , while revenue for the quarter reached $231.67K .
Earnings released on 31 Dec 2022
EPS came in at -$0.10 , while revenue for the quarter reached $207.89K .
Earnings released on 30 Sept 2022
EPS came in at -$0.05 , while revenue for the quarter reached $908.90K .
Earnings released on 30 Jun 2022
EPS came in at -$0.14 , while revenue for the quarter reached $182.73K .
Earnings released on 31 Mar 2022
EPS came in at -$0.08 , while revenue for the quarter reached $99.69K .
Earnings released on 31 Dec 2021
EPS came in at -$0.13 , while revenue for the quarter reached $54.19K .
Earnings released on 30 Sept 2021
EPS came in at -$0.06 , while revenue for the quarter reached $27.05K .
Earnings released on 30 Jun 2021
EPS came in at -$0.04 , while revenue for the quarter reached $126.61K .
Earnings released on 31 Mar 2021
EPS came in at -$0.02 , while revenue for the quarter reached $1.06M .
Earnings released on 31 Dec 2020
EPS came in at -$0.06 , while revenue for the quarter reached $294.73K .
Earnings released on 30 Sept 2020
EPS came in at -$0.06 , while revenue for the quarter reached $137.69K .
IBXXF Stock Performance
Access detailed IBXXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.